Skip to main content
Erschienen in: World Journal of Urology 6/2012

01.12.2012 | Original Article

Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy

verfasst von: Thomas F. Chromecki, Julian Mauermann, Eugene K. Cha, Robert S. Svatek, Harun Fajkovic, Pierre I. Karakiewicz, Yair Lotan, Derya Tilki, Patrick J. Bastian, Bjoern G. Volkmer, Francesco Montorsi, Wassim Kassouf, Giacomo Novara, Hans-Martin Fritsche, Vincenzo Ficarra, Christian G. Stief, Colin P. Dinney, Eila Skinner, Karl Pummer, Yves Fradet, Shahrokh F. Shariat

Erschienen in: World Journal of Urology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Small studies have suggested that older patients have worse outcomes following radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB). We evaluated the association of patient age with clinical outcomes in a large multi-institutional RC series.

Methods

Data were collected from 4,429 patients treated with RC and lymphadenectomy for UCB without neoadjuvant chemotherapy. Age at RC was analyzed both as a continuous and categorical variable.

Results

Higher age at RC, analyzed as a continuous or categorical variable, was associated with advanced pathologic stage (P < 0.001), higher tumor grade (P = 0.045), presence of lymphovascular invasion (P = 0.018), and positive soft-tissue surgical margin status (P = 0.004). Elderly patients were less likely to receive postoperative chemotherapy (P < 0.001). In multivariable analyses, higher age was associated with disease recurrence, cancer-specific, and overall mortality (P < 0.001). Patients ≥80 years had a significantly greater risk of cancer-specific mortality than patients <50 years (HR 1.763, P < 0.001). Age minimally improved the accuracy of a base model that included standard pathologic features for prediction of disease recurrence (+0.2–0.3%) and cancer-specific survival (+0.3%). Conversely, age improved the predictive accuracy for overall survival by a sizeable margin (+4.2–4.5%).

Conclusions

This large external validation study confirms that advanced patient age is minimally but significantly associated with worse prognosis after RC. Nevertheless, a large proportion of elderly patients benefitted from RC with curative intent. We need to improve our understanding of the reasons for the worse UCB outcomes in this growing segment of the population and to develop strategies to improve cancer care in the elderly.
Literatur
1.
Zurück zum Zitat Yancik R, Ries LA (2004) Cancer in older persons: an international issue in an aging world. Semin Oncol 31:128–136PubMedCrossRef Yancik R, Ries LA (2004) Cancer in older persons: an international issue in an aging world. Semin Oncol 31:128–136PubMedCrossRef
2.
Zurück zum Zitat Yancik R, Ries LA (2000) Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14:17–23PubMedCrossRef Yancik R, Ries LA (2000) Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14:17–23PubMedCrossRef
3.
Zurück zum Zitat Edwards BK, Howe HL, Ries LA et al (2002) Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on US cancer burden. Cancer 94:2766–2792PubMedCrossRef Edwards BK, Howe HL, Ries LA et al (2002) Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on US cancer burden. Cancer 94:2766–2792PubMedCrossRef
4.
Zurück zum Zitat Hewitt M, Rowland JH, Yancik R (2003) Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 58:82–91PubMedCrossRef Hewitt M, Rowland JH, Yancik R (2003) Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 58:82–91PubMedCrossRef
6.
Zurück zum Zitat Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR (2008) Late age (85 years or older) peak incidence of bladder cancer. J Urol 179:1302–1305; (discussion 5–6)PubMedCrossRef Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR (2008) Late age (85 years or older) peak incidence of bladder cancer. J Urol 179:1302–1305; (discussion 5–6)PubMedCrossRef
7.
Zurück zum Zitat Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19:666–675PubMed Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19:666–675PubMed
8.
Zurück zum Zitat Madersbacher S, Hochreiter W, Burkhard F et al (2003) Radical cystectomy for bladder cancer today–a homogeneous series without neoadjuvant therapy. J Clin Oncol 21:690–696PubMedCrossRef Madersbacher S, Hochreiter W, Burkhard F et al (2003) Radical cystectomy for bladder cancer today–a homogeneous series without neoadjuvant therapy. J Clin Oncol 21:690–696PubMedCrossRef
9.
Zurück zum Zitat Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol 176:2414–2422; (discussion 22)PubMedCrossRef Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol 176:2414–2422; (discussion 22)PubMedCrossRef
10.
Zurück zum Zitat Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly. Urol Oncol 27:653–667PubMedCrossRef Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly. Urol Oncol 27:653–667PubMedCrossRef
11.
Zurück zum Zitat Prout GJ, Wesley M, Yancik R, Ries L, Havlik R, Edwards B (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104:1638–1647PubMedCrossRef Prout GJ, Wesley M, Yancik R, Ries L, Havlik R, Edwards B (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104:1638–1647PubMedCrossRef
12.
Zurück zum Zitat Hollenbeck BK, Miller DC, Taub D et al (2004) Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 64:292–297PubMedCrossRef Hollenbeck BK, Miller DC, Taub D et al (2004) Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 64:292–297PubMedCrossRef
13.
Zurück zum Zitat Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174PubMedCrossRef Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174PubMedCrossRef
14.
Zurück zum Zitat Isbarn H, Jeldres C, Zini L et al (2009) A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 182:70–77PubMedCrossRef Isbarn H, Jeldres C, Zini L et al (2009) A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 182:70–77PubMedCrossRef
15.
Zurück zum Zitat Froehner M, Brausi MA, Herr HW, Muto G, Studer UE (2009) Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 56:443–454PubMedCrossRef Froehner M, Brausi MA, Herr HW, Muto G, Studer UE (2009) Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 56:443–454PubMedCrossRef
16.
Zurück zum Zitat Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW (2010) Radical cystectomy in octogenarians–does morbidity outweigh the potential survival benefits? J Urol 183:2171–2177PubMedCrossRef Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW (2010) Radical cystectomy in octogenarians–does morbidity outweigh the potential survival benefits? J Urol 183:2171–2177PubMedCrossRef
17.
Zurück zum Zitat Stimson CJ, Chang SS, Barocas DA et al (2010) Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol 184:1296–1300PubMedCrossRef Stimson CJ, Chang SS, Barocas DA et al (2010) Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol 184:1296–1300PubMedCrossRef
18.
Zurück zum Zitat Nielsen M, Shariat S, Karakiewicz P et al (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51:699–706; (discussion 8)PubMedCrossRef Nielsen M, Shariat S, Karakiewicz P et al (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51:699–706; (discussion 8)PubMedCrossRef
19.
Zurück zum Zitat Resorlu B, Beduk Y, Baltaci S, Ergun G, Talas H (2009) The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 103:480–483PubMedCrossRef Resorlu B, Beduk Y, Baltaci S, Ergun G, Talas H (2009) The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 103:480–483PubMedCrossRef
20.
Zurück zum Zitat Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387PubMedCrossRef Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387PubMedCrossRef
21.
Zurück zum Zitat Nielsen M, Palapattu G, Karakiewicz P et al (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 100:1015–1020PubMed Nielsen M, Palapattu G, Karakiewicz P et al (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 100:1015–1020PubMed
22.
Zurück zum Zitat Chang S, Hassan J, Cookson M, Wells N, Smith JJ (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170:1085–1087PubMedCrossRef Chang S, Hassan J, Cookson M, Wells N, Smith JJ (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170:1085–1087PubMedCrossRef
23.
Zurück zum Zitat Gore J, Litwin M, Lai J et al (2010) Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 102:802–811PubMedCrossRef Gore J, Litwin M, Lai J et al (2010) Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 102:802–811PubMedCrossRef
24.
Zurück zum Zitat Konety B, Joslyn S (2003) Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 170:1765–1771PubMedCrossRef Konety B, Joslyn S (2003) Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 170:1765–1771PubMedCrossRef
25.
Zurück zum Zitat Clark P, Stein J, Groshen S et al (2005) Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 104:36–43PubMedCrossRef Clark P, Stein J, Groshen S et al (2005) Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 104:36–43PubMedCrossRef
26.
Zurück zum Zitat Whitmore WF, Marshall VF (1962) Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol 87:853–868 Whitmore WF, Marshall VF (1962) Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol 87:853–868
27.
Zurück zum Zitat Feifer AH, Taylor JM, Tarin TV, Herr HW (2011) Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy. Eur Urol 59:978–984 Feifer AH, Taylor JM, Tarin TV, Herr HW (2011) Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy. Eur Urol 59:978–984
28.
Zurück zum Zitat Karl A, Carroll PR, Gschwend JE et al (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55:826–835PubMedCrossRef Karl A, Carroll PR, Gschwend JE et al (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55:826–835PubMedCrossRef
Metadaten
Titel
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
verfasst von
Thomas F. Chromecki
Julian Mauermann
Eugene K. Cha
Robert S. Svatek
Harun Fajkovic
Pierre I. Karakiewicz
Yair Lotan
Derya Tilki
Patrick J. Bastian
Bjoern G. Volkmer
Francesco Montorsi
Wassim Kassouf
Giacomo Novara
Hans-Martin Fritsche
Vincenzo Ficarra
Christian G. Stief
Colin P. Dinney
Eila Skinner
Karl Pummer
Yves Fradet
Shahrokh F. Shariat
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 6/2012
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-011-0772-2

Weitere Artikel der Ausgabe 6/2012

World Journal of Urology 6/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.